Patients with metastatic castration-sensitive prostate cancer are recommended to be treated with enzalutamide tablets.

Zydus Lifesciences share price will remain in focus on October 3 after the company received tentative approval from the ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, fundraising and ...

Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...

Ahmedabad: Zydus Lifesciences has received the EIR report from the U.S. Food and Drug Administration (USFDA) for the ...

Environmentally, Perfect Day’s precision fermentation technology means it will be less reliant on conventional animal farming ...

Pharma stock engaged in manufacturing and distributing of pharmaceutical products gained traction on Thursday’s trading ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment ...